Using AI to optimize acute dialysis in the ICU
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial uses machine learning to improve how acute dialysis is delivered to ICU patients who need it. It aims to make the treatment more efficient and personalized.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are admitted to the intensive care unit (ICU).
- You need acute dialysis (a type of kidney treatment) urgently.
- You have not received dialysis for less than 24 hours.
- You do not have end-stage kidney disease (permanent kidney failure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests software that uses artificial intelligence to predict if a patient in the ICU might develop acute kidney injury (sudden kidney damage). It aims to see if the software is cost-effective and could help doctors catch problems earlier.
This trial looks at how a type of continuous kidney dialysis, called CRRT, works in very sick patients in the intensive care unit. It may help doctors learn more about how to best care for people who need this treatment.
This study looks at how dialysis (renal replacement therapy) is used for patients in intensive care units (ICUs) with severe acute kidney injury in Latin America. Your participation can help improve care for people with kidney problems.
This trial uses a special monitor (called ANI) to check how well your nervous system is working while you are on continuous kidney dialysis in the ICU. It may help doctors better understand your body's response to fluid removal.
This trial looks at different types of continuous kidney dialysis (CRRT) to see which best helps kidney recovery in ICU patients with sudden kidney injury. It also studies how the dose and timing of dialysis affect long-term kidney function.
This study tests different doses of a continuous blood-filtering treatment for critically ill patients with sudden kidney failure. It may help doctors find the best dose to improve outcomes.
Hear when a new Renal Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.